Form 8-K - Current report:
SEC Accession No. 0001564590-16-016064
Filing Date
2016-04-11
Accepted
2016-04-11 17:06:40
Documents
3
Period of Report
2016-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tbra-8k_20160411.htm 8-K 26786
2 EX-99.1 tbra-ex991_17.htm EX-99.1 21515
3 GRAPHIC gxqznpph1uwp000001.jpg GRAPHIC 4044
  Complete submission text file 0001564590-16-016064.txt   55377
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

EIN.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35953 | Film No.: 161565725
SIC: 2834 Pharmaceutical Preparations